Allogeneic umbilical cord derived mesenchymal stem cell therapy (CytoMed Therapeutics)

N/A

Report date: 2025/03/25 17:31:50

Base Information

Drug NameAllogeneic umbilical cord derived mesenchymal stem cell therapy (CytoMed Therapeutics)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsOsteoarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCytoMed Therapeutics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesCytoMed Therapeutics Ltd

Inactive CompaniesN/A

Active IndicationsOsteoarthritis

Inactive IndicationsN/A

Other Information

ATC CodeN/A